Hypertension and hepatic steatosis
- PMID: 18765087
- DOI: 10.1007/s11906-008-0035-9
Hypertension and hepatic steatosis
Abstract
Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic syndrome. This review discusses the evidence to support this association, and reviews the diagnosis and management of hepatic steatosis.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical